Use of mindronate in cardiac insufficiency in patients with ischemic heart disease

A clinical trial of Soviet drug mildronate has proved its antiarrhythmic action, the ability to prevent ventricular extrasystoles, to reduce asthenia, to enhance physical performance and adaptive reactions. The heart rate decrease appeared insignificant. Intravenous administration of the drug improv...

Full description

Saved in:
Bibliographic Details
Published inKlinicheskaia meditsina Vol. 68; no. 1; p. 39
Main Authors Ol'binskaia, L I, Golokolenova, G M
Format Journal Article
LanguageRussian
Published Russia (Federation) 01.01.1990
Subjects
Adult
Aged
Cardiomyopathy, Dilated - drug therapy
Cardiomyopathy, Dilated - etiology
Cardiomyopathy, Dilated - physiopathology
Clinical Trials as Topic
Coronary Disease - complications
Coronary Disease - physiopathology
Female
Hemodynamics - drug effects
Hemodynamics - physiology
Humans
Male
Methylhydrazines - therapeutic use
Middle Aged
Vasodilator Agents
Online AccessGet more information

Cover

More Information
Summary:A clinical trial of Soviet drug mildronate has proved its antiarrhythmic action, the ability to prevent ventricular extrasystoles, to reduce asthenia, to enhance physical performance and adaptive reactions. The heart rate decrease appeared insignificant. Intravenous administration of the drug improves myocardial contractility. Mildronate is well tolerated. No side effects were registered.
ISSN:0023-2149